Clinical trial
Inclusion Body Myositis Treatment With Celution Processed Adipose Derived Regenerative Cells
NCT04975841 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inclusion Body Myositis Treatment With Celution Processed Adipose Derived Regenerative Cells
- Lead sponsor
- University of Kansas Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 10, 2022
- Completion date
- September 26, 2025
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
inclusion body myositis